Statistics show that counterfeit drugs now make up 5-8 percent ($30 billion) of the pharmaceutical industry's worldwide trade. This growing problem not only reduces profits in the industry, but also puts patient safety at greater risk. In response to this problem, the U.S. Food and Drug Administration (FDA) has pressured the pharmaceutical industry to begin using new preventative measures.
In response to the FDA, The Rutgers Center for Supply Chain Management at Rutgers, the State University of New Jersey, has begun a three-phase study to research the key issues in the pharmaceutical data-sharing program. S. Chan Choi, associate professor of marketing and a member of the research team at Rutgers, will lecture on findings to date at the Whitman School of Management at Syracuse University on Friday, Nov. 10. The event will be held from 2:30-3:50 p.m. in Room 525 of the Whitman School building. It is free and open to the public.
Choi's research interests include modeling price competition in various marketing contexts, competitive product positioning, store brand competition, and pricing captive products such as laboratory equipment and supplies. He has published in top journals in the marketing field, including Marketing Science, Management Science and the Journal of Retailing. He holds a PhD from the Wharton School of Business at the University of Pennsylvania.
